Inflammatory Breast Cancer Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
TKI258 for Metastatic Inflammatory Breast Cancer Patients
Condition: Breast CancerIntervention: Drug: DovitinibSponsors: M.D. Anderson Cancer Center; NovartisRecruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 15, 2010 Category: Research Source Type: clinical trials
MIRNA Profiling of Breast Cancer in Patients Undergoing Neoadjuvant or Adjuvant Treatment for Locally Advanced & Inflammatory Breast Cancer
Condition: Breast CancerIntervention: Sponsor: City of Hope Medical CenterRecruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 29, 2010 Category: Research Source Type: clinical trials
MIRNA Profiling of Breast Cancer in Patients Undergoing Neoadjuvant or Adjuvant Treatment for Locally Advanced & Inflammatory Breast Cancer
Condition: Breast CancerIntervention: Sponsor: City of Hope Medical CenterRecruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 27, 2010 Category: Research Source Type: clinical trials
Panitumumab, Nab-paclitaxel and Carboplatin for HER2 Negative Inflammatory Breast Cancer
Condition: Breast CancerInterventions: Drug: Panitumumab; Drug: Nab-paclitaxel; Drug: Carboplatin; Drug: 5-Fluorouracil; Drug: Epirubicin; Drug: CyclophosphamideSponsors: M.D. Anderson Cancer Center; Celgene Corporation; AmgenRecruiting - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 17, 2009 Category: Research Source Type: clinical trials
Efficacy and Tolerance Study of Bevacizumab in Her2- Inflammatory Breast Cancer Patients
Condition: Breast CancerInterventions: Biological: bevacizumab; Drug: cyclophosphamide; Drug: docetaxel; Drug: epirubicin hydrochloride; Drug: fluorouracilSponsor: UNICANCERActive, not recruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 9, 2009 Category: Research Source Type: clinical trials
Case-Control Study of Inflammatory Breast Cancer in North Africa
Condition: Inflammatory Breast CancerIntervention: Sponsor: National Cancer Institute (NCI)Recruiting - verified November 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 18, 2008 Category: Research Source Type: clinical trials
Case-Control Study of Inflammatory Breast Cancer in North Africa
Condition: Inflammatory Breast CancerIntervention: Sponsor: National Cancer Institute (NCI)Recruiting - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 18, 2008 Category: Research Source Type: clinical trials
Case-Control Study of Inflammatory Breast Cancer in North Africa
Condition: Inflammatory Breast CancerIntervention: Sponsor: National Cancer Institute (NCI)Recruiting - verified November 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 18, 2008 Category: Research Source Type: clinical trials
Inflammatory Breast Cancer (IBC) Registry
Condition: Breast CancerInterventions: Other: Interview; Procedure: Blood and Tissue CollectionSponsors: M.D. Anderson Cancer Center; Susan G. Komen Breast Cancer FoundationRecruiting - verified July 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 18, 2007 Category: Research Source Type: clinical trials